 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Luminex Looks to Target Mid- to Low-Volume MDx Labs with GenturaDx Platform
July 12, 2012
Luminex Looks to Target Mid- to Low-Volume MDx Labs with GenturaDx Platform
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Luminex Combining EraGen, GenturaDx Techs to Reach HT, Lower-Plex, and LDT Markets
December 13, 2012 / PCR Insider - Luminex Provides Update on GenturaDx Integration, MDx Pipeline Activities amid Q3 Earnings
November 1, 2012 / PCR Insider - Luminex Leveraging Advanced Liquid Logic Alliance to Develop Field-based MDx/Immunoassay System
May 16, 2013 / PCR Insider - Luminex's 2013 Priorities Include GPP, NeoPlex Adoption, MagPix Placements, Project Aries
February 5, 2013 / BioArray News - GenturaDx Touts Sensitivity of HSV Assay on Beta Version of Integrated Molecular Dx Platform
September 29, 2011 / PCR Insider